Indication
Metastatic colorectal cancer
Metastatic colorectal cancer refers to advanced, stage IV malignancy arising from the epithelial lining of the large intestine—either the colon or the rectum—that has disseminated beyond local regional structures. Read more about Metastatic colorectal cancer
114 drugs 78 manufacturers
Drugs that treat it
Common Metastatic colorectal cancer therapies.
CAMPTOSAR (irinotecan HCl)
OXALIPLATIN
OXALIPLATIN
AVASTIN (bevacizumab)
XELODA (capecitabine)
IRINOTECAN HCL
ADRUCIL (fluorouracil)
IRINOTECAN (irinotecan HCl)
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonMetastatic colorectal cancer refers to advanced, stage IV malignancy arising from the epithelial lining of the large intestine—either the colon or the rectum—that has disseminated beyond local regional structures.
Tumor cells spread hematogenously, via the lymphatic system, or through peritoneal seeding, most commonly establishing secondary lesions in the liver, lungs, distant lymph nodes, and peritoneum.
Clinically, affected patients may present with bowel obstruction, hematochezia, and cachexia, as well as organ-specific manifestations of distant spread such as hepatomegaly, jaundice, or dyspnea.
Pathophysiologically, the disease is driven by the progressive accumulation of genomic and epigenetic alterations, frequently involving mutations in key oncogenic drivers such as *KRAS*, *NRAS*, or *BRAF*, along with distinct microsatellite instability or mismatch repair statuses.
- cancersupportcommunity.org
Metastatic colorectal cancer refers to advanced, stage IV malignancy arising from the epithelial lining of the large intestine—either the colon or the rectum—that has disseminated beyond local regional structures
- mvasi.com
Metastatic colorectal cancer refers to advanced, stage IV malignancy arising from the epithelial lining of the large intestine—either the colon or the rectum—that has disseminated beyond local regional structures Clinically, affected patients may present with bowel obstruction, hematochezia, and cachexia, as well as organ-specific manifestations of distant spread such as hepatomegaly, jaundice, or dyspnea
- cigna.com
Tumor cells spread hematogenously, via the lymphatic system, or through peritoneal seeding, most commonly establishing secondary lesions in the liver, lungs, distant lymph nodes, and peritoneum
- carenity.us
Tumor cells spread hematogenously, via the lymphatic system, or through peritoneal seeding, most commonly establishing secondary lesions in the liver, lungs, distant lymph nodes, and peritoneum Clinically, affected patients may present with bowel obstruction, hematochezia, and cachexia, as well as organ-specific manifestations of distant spread such as hepatomegaly, jaundice, or dyspnea
- nih.gov
Pathophysiologically, the disease is driven by the progressive accumulation of genomic and epigenetic alterations, frequently involving mutations in key oncogenic drivers such as *KRAS*, *NRAS*, or *BRAF*, along with distinct microsatellite instability or mismatch repair statuses
Personalize your experience
Follow Metastatic colorectal cancer and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.